SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Granules India - Quaterly Results

24 Jan 2026 Evaluate
The revenue zoomed 6.31% to Rs. 8953.18 millions for the quarter ended December 2025 as compared to Rs. 8421.96 millions during the corresponding quarter last year.Profit saw a slight increase of 23.83%to Rs. 1115.82  millions from Rs. 901.11 millions.Operating profit surged to 2063.64 millions from the corresponding previous quarter of 1734.78 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 8953.18 8421.96 6.31 25971.39 22621.37 14.81 30301.63 37550.91 -19.31
Other Income 120.79 56.07 115.43 331.16 101.95 224.83 406.80 57.77 604.17
PBIDT 2063.64 1734.78 18.96 5824.51 4580.84 27.15 6054.84 8071.37 -24.98
Interest 154.02 172.14 -10.53 457.28 492.93 -7.23 627.80 719.98 -12.80
PBDT 1909.62 1562.64 22.20 5245.63 4087.91 28.32 5734.54 7351.39 -21.99
Depreciation 405.85 376.63 7.76 1208.33 1082.57 11.62 1462.30 1438.48 1.66
PBT 1503.77 1186.01 26.79 4037.30 3005.34 34.34 4272.24 5912.91 -27.75
TAX 387.95 284.90 36.17 1020.50 752.52 35.61 1078.88 1553.73 -30.56
Deferred Tax -16.94 16.54 -202.42 -45.49 41.91 -208.54 -19.91 47.68 -141.76
PAT 1115.82 901.11 23.83 3016.80 2252.82 33.91 3193.36 4359.18 -26.74
Equity 242.67 242.49 0.07 242.67 242.49 0.07 242.54 242.37 0.07
PBIDTM(%) 23.05 20.60 11.90 22.43 20.25 10.75 19.98 21.49 -7.04

Granules India Share Price

654.40 3.60 (0.55%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×